Journal of International Oncology ›› 2013, Vol. 40 ›› Issue (3): 170-173.

Previous Articles     Next Articles

Oncogenic mechanism and biological effect of Evi-1 gene

DING  Xiang-Ping, ZHANG  Jin-Hua   

  1. Department of  Gastroenterology, Second People’s Hospital of GansuProvince, Lanzhou 730030, China
  • Online:2013-03-08 Published:2013-02-25
  • Contact: ZHANG Jin-hua, E-mail: zjh51272@163.com E-mail:zjh51272@163.com

Abstract: Ecotropic viral integration site-1 (Evi-1) gene is first identified as a binding site for retrovirus in murine myeloid leukemia. The human homologue with the murine in leukemia oncogene Evi-1 is about 91% of nuclear sequence and 94% of amino acid. Evi-1 gene is high expressed in myeloid malignancies and other tumors. The main tumorigenic mechanisms of Evi-1 gene include inhibiting TGF-β signal path by depressing Smad3, adjusting cell cycle, promoting angiogenesis, inhibiting JNK, activating AP-1, and so on.

Key words:  Evi-1 gene, Smad3 protein, Leukemia, TGF-&beta, signal transduction, Neoplasms